
People who got a first dose of AstraZeneca Plc’s shot followed by Pfizer Inc.’s vaccine four weeks later reported more short-lived side effects, most of them mild, study said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3tOHxIQ
via
IFTTT
0 comments:
Post a Comment